
Evaxion A/S — Investor Relations & Filings
Evaxion A/S is a clinical-stage TechBio company specializing in the development of immunotherapies using its proprietary, clinically validated AI-Immunology™ platform. The platform leverages artificial intelligence and machine learning to decode the human immune system, enabling the rapid discovery and design of novel vaccine targets. Evaxion focuses on creating personalized and precision vaccines for the treatment of cancer and infectious diseases. Its pipeline includes personalized cancer vaccines in clinical development, such as EVX-01 for melanoma, and a preclinical portfolio targeting infectious diseases. The company's technology aims to accelerate the development of tailored vaccine candidates to address critical diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Evaxion A/S (0001828253) (Filer) | 2026-05-12 | English | |
| 6-K - Evaxion A/S (0001828253) (Filer) | 2026-05-07 | English | |
| 6-K - Evaxion A/S (0001828253) (Filer) | 2026-05-04 | English | |
| 6-K - Evaxion A/S (0001828253) (Filer) | 2026-04-27 | English | |
| 6-K - Evaxion A/S (0001828253) (Filer) | 2026-04-22 | English | |
| 6-K - Evaxion A/S (0001828253) (Filer) | 2026-04-17 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
KIM FOREST
Offers integrated precision medicine and molecular diagnost…
|
6645 | TW | Professional, scientific and te… |
|
Kura Oncology, Inc.
Clinical-stage biopharma company developing precision medic…
|
KURA | US | Professional, scientific and te… |
|
LAB Research Inc.
Global non-clinical CRO specializing in contract research, …
|
LRI | CA | Professional, scientific and te… |
|
Laekna, Inc.
Clinical-stage biotech developing novel therapies for oncol…
|
2105 | HK | Professional, scientific and te… |
|
Larimar Therapeutics, Inc.
A clinical-stage biotech developing treatments for complex …
|
LRMR | US | Professional, scientific and te… |
|
Lexaria Bioscience Corp.
A biotech company with a patented platform to improve oral …
|
LEXX | US | Professional, scientific and te… |
|
LigaChem Biosciences Inc.
Clinical-stage biopharma developing ADCs, immuno-oncology d…
|
141080 | KR | Professional, scientific and te… |
|
Linical Co., Ltd.
A global CRO providing a full spectrum of drug development …
|
2183 | JP | Professional, scientific and te… |
|
Lipigon Pharmaceuticals AB
A clinical-stage company developing therapeutics for lipid-…
|
LPGO | SE | Professional, scientific and te… |
|
Lipum AB
Clinical-stage biopharma developing novel treatments for ch…
|
LIPUM | SE | Professional, scientific and te… |
Evaxion A/S via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34884/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34884 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34884 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34884 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34884}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Evaxion A/S (id: 34884)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.